CHEK1 and cancer: Notably, in a pan-cancer analysis of TCGA, Pan-China, and Memorial Sloan Kettering Cancer Center (MSKCC) data (Fig. 7I), ATR is the only cell cycle checkpoint kinase that is comutated with TP53 in all three datasets (cumulative log2 odds ratio = 0.968, cumulative q < 0.001).